EP Patent

EP3449908A1 — Desmopressin for reducing nocturnal voids

Assigned to Ferring BV · Expires 2019-03-06 · 7y expired

What this patent protects

The present disclosure is directed to reducing nocturnal voids by administering a dose of desmopressin.

USPTO Abstract

The present disclosure is directed to reducing nocturnal voids by administering a dose of desmopressin.

Drugs covered by this patent

desmopressin-acetate (DESMOPRESSIN ACETATE)

Patent Metadata

Patent number: EP3449908A1
Jurisdiction: EP
Classification: —
Expires: 2019-03-06
Drug substance claim: No
Drug product claim: No
Assignee: Ferring BV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.